7-151014116-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_000603.5(NOS3):​c.3559G>A​(p.Gly1187Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,138 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

NOS3
NM_000603.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.46
Variant links:
Genes affected
NOS3 (HGNC:7876): (nitric oxide synthase 3) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ATG9B (HGNC:21899): (autophagy related 9B) This gene functions in the regulation of autophagy, a lysosomal degradation pathway. This gene also functions as an antisense transcript in the posttranscriptional regulation of the endothelial nitric oxide synthase 3 gene, which has 3' overlap with this gene on the opposite strand. Mutations in this gene and disruption of the autophagy process have been associated with multiple cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06030163).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NOS3NM_000603.5 linkuse as main transcriptc.3559G>A p.Gly1187Ser missense_variant 27/27 ENST00000297494.8
ATG9BNR_073169.1 linkuse as main transcriptn.2423C>T non_coding_transcript_exon_variant 16/18
ATG9BNR_133652.1 linkuse as main transcriptn.3160C>T non_coding_transcript_exon_variant 15/17
ATG9BXR_007060009.1 linkuse as main transcriptn.3034C>T non_coding_transcript_exon_variant 14/15

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NOS3ENST00000297494.8 linkuse as main transcriptc.3559G>A p.Gly1187Ser missense_variant 27/271 NM_000603.5 P1P29474-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD3 exomes
AF:
0.00000800
AC:
2
AN:
249980
Hom.:
0
AF XY:
0.00000738
AC XY:
1
AN XY:
135498
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000545
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461138
Hom.:
0
Cov.:
35
AF XY:
0.00000275
AC XY:
2
AN XY:
726812
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.00e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 13, 2023The c.3559G>A (p.G1187S) alteration is located in exon 27 (coding exon 26) of the NOS3 gene. This alteration results from a G to A substitution at nucleotide position 3559, causing the glycine (G) at amino acid position 1187 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
23
DANN
Benign
0.90
DEOGEN2
Benign
0.10
T;T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.37
N
LIST_S2
Benign
0.73
T;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.060
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.20
N;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.060
N;N
REVEL
Benign
0.021
Sift
Benign
0.068
T;T
Sift4G
Benign
0.11
T;T
Polyphen
0.0010
B;B
Vest4
0.13
MutPred
0.24
Gain of disorder (P = 0.0412);.;
MVP
0.25
MPC
0.50
ClinPred
0.072
T
GERP RS
-0.32
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.044
gMVP
0.92

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs541336826; hg19: chr7-150711204; API